Collectively, these findings indicate that IGFL1 promotes CRC pathogenesis and progression through the suppression of lipophagy.<h4>Conclusions</h4>IGFL1 exhibits oncogenic properties in colorectal cancer and may represent a potential therapeutic target. Here, IGFL1 is linked to colorectal carcinoma.